Companies / Metagenomi Therapeutics, Inc. / Activity
Activity — Metagenomi Therapeutics, Inc.
18 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q4 2025 as of | Norges Bank 13F manager | Exit | Common Stock | $-343.1K | -252K -100.00% | 0 | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | Add | Common Stock | $213.7K | +160K +25.38% | 787,900 2.09% of shares | low |
| Q4 2024 as of | Barclays PLC 13F manager | Add | Common Stock | $122.0K | +34K +388.40% | 42,481 0.11% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Trim | Common Stock | $-87.2K | -65K -27.67% | 170,104 0.45% of shares | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | Common Stock | $74.2K | +55K +12.55% | 496,767 1.31% of shares | low |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common Stock | $70.1K | +52K +17.09% | 358,200 0.95% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Trim | Common Stock | $-69.2K | -52K -65.22% | 27,521 0.07% of shares | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | Exit | Common Stock | $-54.9K | -34K -100.00% | 0 | low |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common Stock | $39.9K | +33K +14.94% | 257,631 0.68% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | Trim | Common Stock | $-38.5K | -29K -99.99% | 3 <0.01% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Trim | Common Stock | $-30.3K | -19K -99.78% | 42 <0.01% of shares | low |
| Q1 2025 as of | Barclays PLC 13F manager | Trim | Common Stock | $-18.5K | -14K -32.09% | 28,848 0.08% of shares | low |
| Q2 2026 as of | LPL Financial LLC 13F manager | Exit | Common Stock | $-18.3K | -11K -100.00% | 0 | low |
| Q3 2024 as of | Barclays PLC 13F manager | Add | Common Stock | $14.2K | +7K +301.57% | 8,698 0.02% of shares | low |
| Q2 2024 as of | Barclays PLC 13F manager | New | Common Stock | $8.8K | +2K | 2,166 <0.01% of shares | low |
| Q1 2026 as of | MassMutual Private Wealth & Trust, FSB 13F manager | Exit | Common Stock | $-961 | -593 -100.00% | 0 | low |
| Q2 2026 as of | State Street Corporation 13F manager | Trim | Common Stock | $-687 | -577 -0.48% | 119,850 0.32% of shares | low |
| Q1 2026 as of | Royal Bank of Canada 13F manager | Add | Common Stock | $0 | +291 +1265.22% | 314 <0.01% of shares | low |